XML 40 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings per Share ("EPS") (Tables)
 9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Reconciliation of numerator and denominator used in computation of earnings per share
The following table reconciles the numerator and denominator used in the computation of EPS for the three and nine months ended September 30, 2017 and 2016 (shares in thousands):
 
For the Three Months Ended September 30,
 
For the Nine Months Ended September 30,
 
2017
 
2016
 
2017
 
2016
Numerator
 
 
 
 
 
 
 
Net income
$
19,228

 
$
13,196

 
$
123,089

 
$
514,005

Net income attributable to noncontrolling interests
(1,730
)
 
534

 
(9,710
)
 
(34,138
)
Net income attributable to the Company
17,498

 
13,730

 
113,379

 
479,867

Allocation of earnings to participating securities
(193
)
 
(170
)
 
(567
)
 
(586
)
Numerator for basic and diluted EPS—net income attributable to common stockholders
$
17,305

 
$
13,560

 
$
112,812

 
$
479,281

Denominator
 
 
 
 
 
 
 
Denominator for basic EPS—weighted average number of common shares outstanding
141,299

 
143,923

 
142,188

 
147,504

Effect of dilutive securities(1):
 
 
 
 
 
 
 
Share and unit-based compensation plans
11

 
113

 
35

 
126

Denominator for diluted EPS—weighted average number of common shares outstanding
141,310

 
144,036

 
142,223

 
147,630

Earnings per common share—net income attributable to common stockholders:
 
 
 
 
 
 
 
Basic
$
0.12

 
$
0.09

 
$
0.79

 
$
3.25

Diluted
$
0.12

 
$
0.09

 
$
0.79

 
$
3.25

 
 
 
(1)
Diluted EPS excludes 90,619 and 138,759 convertible preferred partnership units for the three months ended September 30, 2017 and 2016, respectively, and 90,619 and 138,759 convertible preferred partnership units for the nine months ended September 30, 2017 and 2016, respectively, as their impact was antidilutive.
Diluted EPS excludes 10,324,376 and 10,666,565 Operating Partnership units ("OP Units") for the three months ended September 30, 2017 and 2016, respectively, and 10,479,806 and 10,773,029 OP Units for the nine months ended September 30, 2017 and 2016, respectively, as their impact was antidilutive.